Bristol-Myers Loses Canadian Court Battle Over Taxol Alternative
A tiny Canadian drug maker has defeated U.S. drug giant Bristol-Myers Squibb Co. in a five-year patent battle over the right to sell an inexpensive cancer treatment that would compete with...To view the full article, register now.
Already a subscriber? Click here to view full article